Tokyo, Oct. 20 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059458) titled 'Evaluation of shape and size of ocular globe' on Oct. 19.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Self control
Primary Sponsor:
Institute - Fujita health university
Condition:
Condition - Retinal detachment, lens dislocation, IOL dislocation, myopic eyes
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Evaluation of the shape and size of the ocular globe.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - MRI
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients visiting the Department of Ophthalmology, Fujita Health University.
Key exclusion criteria - subjects unable to undergo MRI.
Target Size - 120
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2025 Year 10 Month 08 Day
Date of IRB - 2025 Year 10 Month 08 Day
Anticipated trial start date - 2025 Year 10 Month 20 Day
Last follow-up date - 2030 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065987
Disclaimer: Curated by HT Syndication.
